Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 1
1950 1
1952 5
1953 2
1954 7
1955 7
1956 1
1957 2
1958 3
1959 3
1960 1
1964 7
1965 13
1966 7
1967 11
1968 11
1969 10
1970 12
1971 6
1972 6
1973 11
1974 9
1975 11
1976 18
1977 19
1978 22
1979 26
1980 18
1981 22
1982 28
1983 37
1984 40
1985 30
1986 37
1987 31
1988 39
1989 58
1990 47
1991 49
1992 62
1993 40
1994 58
1995 52
1996 54
1997 87
1998 80
1999 82
2000 98
2001 100
2002 129
2003 145
2004 147
2005 207
2006 155
2007 175
2008 202
2009 170
2010 168
2011 186
2012 207
2013 183
2014 213
2015 255
2016 265
2017 270
2018 322
2019 384
2020 398
2021 406
2022 418
2023 455
2024 200

Text availability

Article attribute

Article type

Publication date

Search Results

6,348 results

Results by year

Filters applied: . Clear all
Page 1
Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.
Fishbein AB, Silverberg JI, Wilson EJ, Ong PY. Fishbein AB, et al. J Allergy Clin Immunol Pract. 2020 Jan;8(1):91-101. doi: 10.1016/j.jaip.2019.06.044. Epub 2019 Aug 29. J Allergy Clin Immunol Pract. 2020. PMID: 31474543 Free PMC article. Review.
Atopic dermatitis (AD) is one of the most common inflammatory skin diseases affecting children and adults. ...This article provides an overview of AD, including strategies for differential diagnosis and assessment of disease severity to guide treatment …
Atopic dermatitis (AD) is one of the most common inflammatory skin diseases affecting children and adults. ...This arti …
Atopic dermatitis in children.
Strathie Page S, Weston S, Loh R. Strathie Page S, et al. Aust Fam Physician. 2016 May;45(5):293-6. Aust Fam Physician. 2016. PMID: 27166464 Free article. Review.
BACKGROUND: Atopic dermatitis is a frequent reason for presentation to general practice. ...Making GPs confident and knowledgeable about atopic dermatitis will make the interaction between the practitioner, families and children more rewarding.. …
BACKGROUND: Atopic dermatitis is a frequent reason for presentation to general practice. ...Making GPs confident and knowledge …
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting.
Eichenfield LF, Stripling S, Fung S, Cha A, O'Brien A, Schachner LA. Eichenfield LF, et al. Paediatr Drugs. 2022 Jul;24(4):293-305. doi: 10.1007/s40272-022-00499-x. Epub 2022 Jun 13. Paediatr Drugs. 2022. PMID: 35698002 Free PMC article. Review.
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial number of children and has a significant negative impact on affected patients and their caregivers/families. ...In addition, the article highlights recent advances in sc …
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial number of children and has a …
Guidelines for the Management of Atopic Dermatitis in Children: A Systematic Review.
Wang Q, Liu L, Gao S, Su S. Wang Q, et al. Int Arch Allergy Immunol. 2023;184(2):132-141. doi: 10.1159/000527007. Epub 2022 Nov 2. Int Arch Allergy Immunol. 2023. PMID: 36323240
INTRODUCTION: Numerous guidelines have been published for atopic dermatitis management in children in recent years. To date, the quality of the newest guidelines has not been appraised. ...No significant changes were observed in the primary management of a …
INTRODUCTION: Numerous guidelines have been published for atopic dermatitis management in children in recent years. To …
What's New in Topicals for Atopic Dermatitis?
Kleinman E, Laborada J, Metterle L, Eichenfield LF. Kleinman E, et al. Am J Clin Dermatol. 2022 Sep;23(5):595-603. doi: 10.1007/s40257-022-00712-0. Epub 2022 Sep 1. Am J Clin Dermatol. 2022. PMID: 36048410 Free PMC article. Review.
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can have tremendous impact on quality of life for affected children and adults. ...We are now in an unprecedented time with more than 40 topical treatments in the pipeline for AD in a …
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can have tremendous impact on quality of life for affecte …
Treatment With Dupilumab in Patients With Atopic Dermatitis: Systematic Review and Meta-Analysis.
Koskeridis F, Evangelou E, Ntzani EE, Kostikas K, Tsabouri S. Koskeridis F, et al. J Cutan Med Surg. 2022 Nov-Dec;26(6):613-621. doi: 10.1177/12034754221130969. Epub 2022 Oct 9. J Cutan Med Surg. 2022. PMID: 36214355 Review.
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decreasing the quality of life for many patients. ...Dupilumab decreased the Eczema Area Severity Index (EASI) score [standardized mean difference (SMD) …
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decreasing th …
Clinical practice guidelines for the diagnosis and management of atopic dermatitis.
Kulthanan K, Tuchinda P, Nitiyarom R, Chunharas A, Chantaphakul H, Aunhachoke K, Chularojanamontri L, Rajatanavin N, Jirapongsananuruk O, Vichyanond P, Chatchatee P, Sangsupawanich P, Wananukul S, Singalavanija S, Trakanwittayarak S, Rerkpattanapipat T, Thongngarm T, Wisuthsarewong W, Limpongsanurak W, Kamchaisatian W, Noppakun N. Kulthanan K, et al. Asian Pac J Allergy Immunol. 2021 Sep;39(3):145-155. doi: 10.12932/AP-010221-1050. Asian Pac J Allergy Immunol. 2021. PMID: 34246205 Free article.
Atopic dermatitis (AD), a chronic, relapsing dermatitis, is characterized by dry and pruritus skin in patients with a personal or family history of atopy. It affects up to 20% of children and 1-3% of adults in most countries worldwide, and leads to sig …
Atopic dermatitis (AD), a chronic, relapsing dermatitis, is characterized by dry and pruritus skin in patients with a p …
Update on Atopic Dermatitis.
Kellogg C, Smogorzewski J. Kellogg C, et al. Adv Pediatr. 2023 Aug;70(1):157-170. doi: 10.1016/j.yapd.2023.03.006. Epub 2023 May 5. Adv Pediatr. 2023. PMID: 37422293 Review.
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with a lifetime prevalence of up to 20% which can occur at any age but is most common among children. There is a significant burden of pediatric AD in the primary care setting; thus, the ability t …
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with a lifetime prevalence of up to 20% which can occur at any …
Atopic dermatitis endotypes and implications for targeted therapeutics.
Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Czarnowicki T, et al. J Allergy Clin Immunol. 2019 Jan;143(1):1-11. doi: 10.1016/j.jaci.2018.10.032. J Allergy Clin Immunol. 2019. PMID: 30612663 Review.
Recent research advancements indicate that atopic dermatitis (AD) is a complex disease characterized by different subtypes/phenotypes based on age, disease chronicity, ethnicity, filaggrin and IgE status, and underlying molecular mechanisms/endotypes. ...Precision m …
Recent research advancements indicate that atopic dermatitis (AD) is a complex disease characterized by different subtypes/phe …
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
Chan S, Cornelius V, Cro S, Harper JI, Lack G. Chan S, et al. JAMA Pediatr. 2020 Jan 1;174(1):29-37. doi: 10.1001/jamapediatrics.2019.4476. JAMA Pediatr. 2020. PMID: 31764962 Free PMC article. Clinical Trial.
IMPORTANCE: Systemic treatments for severe childhood atopic dermatitis have limited evidence and/or are unlicensed. Despite the efficacy of anti-IgE medication (omalizumab) in the treatment of atopy, no large randomized studies in childhood atopic …
IMPORTANCE: Systemic treatments for severe childhood atopic dermatitis have limited evidence and/or are unlicensed. Des …
6,348 results